Biomea Fusion, Inc. (BMEA) Financials

BMEA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 36.9 million 24.7 million
March 31, 2026 46.4 million 27.7 million
Dec. 31, 2025 58.6 million 29.0 million
Sept. 30, 2025 55.2 million 39.6 million

BMEA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -10.0 million 1.6 million
March 31, 2026 -11.7 million 1.6 million
Dec. 31, 2025 -13.2 million 1.8 million
Sept. 30, 2025 -12.2 million 1.9 million

BMEA Net Income

No data available :(

BMEA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 34.8 million - 877000
March 31, 2026 44.7 million - 1.2 million
Dec. 31, 2025 55.8 million - 128000
Sept. 30, 2025 46.6 million - 6.9 million

BMEA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 72.4 million
March 31, 2026 72.3 million
Dec. 31, 2025 72.3 million
Sept. 30, 2025 40.6 million

BMEA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 9.1 million 3.6 million -
March 31, 2026 - 9.1 million 3.7 million -
Dec. 31, 2025 - 8.1 million 3.6 million -
Sept. 30, 2025 - 14.4 million 4.2 million -

BMEA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 46000
Dec. 31, 2025 - 47000
Sept. 30, 2025 - 400000

BMEA

Price: $0.87

52 week price:
0.83
2.99

Earnings Per Share: -0.18 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 55800

Market Capitalization: 91.8 million

Links: